# FDA Inspection 677263 - AMAG Pharma USA, Inc. - August 20, 2010

Source: https://www.keypedia.com/records/fda_inspections/amag-pharma-usa-inc/53e13c1d-1df0-4ff6-a6cd-d0924e24870d
Source feed: FDA_Inspections

> FDA Inspection 677263 for AMAG Pharma USA, Inc. on August 20, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 677263
- Company Name: AMAG Pharma USA, Inc.
- Inspection Date: 2010-08-20
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 709390 - 2011-02-11](https://www.keypedia.com/records/fda_inspections/amag-pharma-usa-inc/80e954fa-382f-4f44-a51e-94724d9bbb81)
- [FDA Inspection 568770 - 2009-02-02](https://www.keypedia.com/records/fda_inspections/amag-pharma-usa-inc/f0a7744f-1144-4359-8277-ebaa4c3d965a)

Company: https://www.keypedia.com/companies/amag-pharma-usa-inc/27f49f66-d904-43f6-b3b3-f29c210d47e3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c